ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000

Patients Prefer Silicone Over Saline Implants

November 26, 2010

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

U. Arizona Center Finds a Way To Community Rapport

January 18, 1980

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993